A
Andrew Timmes
Researcher at National Institutes of Health
Publications - 5
Citations - 496
Andrew Timmes is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Scrapie & PrPSc Proteins. The author has an hindex of 5, co-authored 5 publications receiving 434 citations.
Papers
More filters
Journal ArticleDOI
Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays
Jason M. Wilham,Christina D. Orrú,Christina D. Orrú,Richard A. Bessen,Ryuichiro Atarashi,Kazunori Sano,Brent Race,Kimberly Meade-White,Lara M. Taubner,Andrew Timmes,Byron Caughey +10 more
TL;DR: End point dilution RT-QuIC provides a sensitive, rapid, quantitative, and high throughput assay of prion seeding activity and can be accomplished in 2 days or less.
Journal ArticleDOI
Recombinant Prion Protein Refolded with Lipid and RNA Has the Biochemical Hallmarks of a Prion but Lacks In Vivo Infectivity
TL;DR: The results demonstrate that the ability to self-propagate into a protease-resistant insoluble conformer is not unique to infectious PrP molecules and suggest that the presence of RNA and lipid cofactors may facilitate the spontaneous refolding of PrP into an infectious form while also allowing the de novo formation ofSelf-propagating, but non-infectious, rPrP-res.
Journal ArticleDOI
Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations
TL;DR: The similarities between PrPSc samples from 22L and Chandler TSE strains suggest that the non‐PrPSc protein components found in standard enrichment protocols are not strain specific.
Journal ArticleDOI
Identification and removal of proteins that co‐purify with infectious prion protein improves the analysis of its secondary structure
TL;DR: The results show that contaminating proteins alter the FTIR spectrum attributed to PrPSc and suggest that the α‐helical, loop/turn and β‐sheet secondary structure that remains following their removal are derived from PrP sc itself.
Journal ArticleDOI
Co-infection with the friend retrovirus and mouse scrapie does not alter prion disease pathogenesis in susceptible mice.
Pascal Leblanc,Kim J. Hasenkrug,Anne Ward,Lara Myers,Ronald J. Messer,Sandrine Alais,Sandrine Alais,Sandrine Alais,Andrew Timmes,Suzette A. Priola +9 more
TL;DR: It is shown that another retrovirus, the murine leukemia virus Friend (F-MuLV), also enhanced the release and spread of scrapie infectivity in cell culture, but retroviral co-infection does not necessarily alter prion disease pathogenesis in vivo.